AstraZeneca Names Roche’s Soriot as CEO

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

AstraZeneca Plc named Pascal Soriot, Roche Holding AG’s head of pharmaceuticals, as chief executive officer to revive sales and product development as the U.K. company faces one of the industry’s biggest patent expirations.

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change